| Pharmaceutical Information |
| Drug Name |
Procyclidine hydrochloride |
| Drug ID |
BADD_D01851 |
| Description |
A muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism. |
| Indications and Usage |
For the treatment of all forms of Parkinson's Disease, as well as control of extrapyramidal reactions induced by antipsychotic agents. |
| Marketing Status |
Discontinued |
| ATC Code |
N04AA04 |
| DrugBank ID |
DB00387
|
| KEGG ID |
D00782
|
| MeSH ID |
D011352
|
| PubChem ID |
207837
|
| TTD Drug ID |
D0R1WR
|
| NDC Product Code |
17337-0090 |
| Synonyms |
Procyclidine | Tricyclamol | Procyclidine Hydrochloride | Hydrochloride, Procyclidine | Kemadren | Mucinil | Procyclid | Kemadrin | Osnervan | Arpicolin |
|
| Chemical Information |
| Molecular Formula |
C19H30ClNO |
| CAS Registry Number |
30953-82-3 |
| SMILES |
C1CCC(CC1)C(CCN2CCCC2)(C3=CC=CC=C3)O.Cl |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
